BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34070036)

  • 1. Epigenetic Insights and Potential Modifiers as Therapeutic Targets in
    Zakaria NA; Islam MA; Abdullah WZ; Bahar R; Mohamed Yusoff AA; Abdul Wahab R; Shamsuddin S; Johan MF
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34070036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.
    Chondrou V; Stavrou EF; Markopoulos G; Kouraklis-Symeonidis A; Fotopoulos V; Symeonidis A; Vlachaki E; Chalkia P; Patrinos GP; Papachatzopoulou A; Sgourou A
    Hum Genomics; 2018 Oct; 12(1):45. PubMed ID: 30285874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation patterns of β-globin cluster in β-thalassemia patients.
    Bao X; Zuo Y; Chen D; Zhao C
    Clin Epigenetics; 2020 Dec; 12(1):187. PubMed ID: 33272312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.
    Kolliopoulou A; Siamoglou S; John A; Sgourou A; Kourakli A; Symeonidis A; Vlachaki E; Chalkia P; Theodoridou S; Ali BR; Katsila T; Patrinos GP; Papachatzopoulou A
    Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
    Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
    Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
    Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
    Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
    Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
    Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β
    Khamphikham P; Sripichai O; Munkongdee T; Fucharoen S; Tongsima S; Smith DR
    Int J Hematol; 2018 Mar; 107(3):297-310. PubMed ID: 29067594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.
    Danjou F; Anni F; Perseu L; Satta S; Dessì C; Lai ME; Fortina P; Devoto M; Galanello R
    Haematologica; 2012 Jul; 97(7):989-93. PubMed ID: 22271886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Understanding of Non-Transfusion-Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia in Northeast Thailand.
    Yamsri S; Pakdee N; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Acta Haematol; 2016; 136(4):233-239. PubMed ID: 27710960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia.
    Gong Y; Zhang X; Zhang Q; Zhang Y; Ye Y; Yu W; Shao C; Yan T; Huang J; Zhong J; Wang L; Li Y; Wang L; Xu X
    Blood; 2021 Mar; 137(12):1652-1657. PubMed ID: 33227819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells.
    Chumchuen S; Sripichai O; Jearawiriyapaisarn N; Fucharoen S; Peerapittayamongkol C
    PLoS One; 2023; 18(3):e0281059. PubMed ID: 36888630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.
    Razak SAA; Murad NAA; Masra F; Chong DLS; Abdullah N; Jalil N; Alauddin H; Sabudin RZAR; Ithnin A; Khai LC; Aziz NA; Muda Z; Ibrahim H; Latiff ZA
    Curr Mol Med; 2018; 18(5):295-305. PubMed ID: 30289070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Aγ-globin G->A gene polymorphism associated with β
    Breveglieri G; Bianchi N; Cosenza LC; Gamberini MR; Chiavilli F; Zuccato C; Montagner G; Borgatti M; Lampronti I; Finotti A; Gambari R
    BMC Med Genet; 2017 Aug; 18(1):93. PubMed ID: 28851297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
    Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
    Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.
    Hariharan P; Sawant M; Gorivale M; Manchanda R; Colah R; Ghosh K; Nadkarni A
    Mol Biol Rep; 2017 Oct; 44(5):413-417. PubMed ID: 28879539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major.
    Fanis P; Kousiappa I; Phylactides M; Kyrri A; Hadjigavriel M; Christou S; Sitarou M; Kleanthous M
    Hum Mutat; 2019 Oct; 40(10):1768-1780. PubMed ID: 31115947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of β thalassemia and potential therapeutic targets.
    Thein SL
    Blood Cells Mol Dis; 2018 May; 70():54-65. PubMed ID: 28651846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Genetic Variant Ameliorates β-Thalassemia Severity by Epigenetic-Mediated Elevation of Human Fetal Hemoglobin Expression.
    Chen D; Zuo Y; Zhang X; Ye Y; Bao X; Huang H; Tepakhan W; Wang L; Ju J; Chen G; Zheng M; Liu D; Huang S; Zong L; Li C; Chen Y; Zheng C; Shi L; Zhao Q; Wu Q; Fucharoen S; Zhao C; Xu X
    Am J Hum Genet; 2017 Jul; 101(1):130-138. PubMed ID: 28669403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.